Riskpilot← Back to searchSign inGet full accessMEDTHINGS AS
ASActiveOrg 924455314Mosseveien 109, 1624 GressvikEngineering activities and related technical consultancy · NACE 7112Est. 20205 employees
Revenue 2024
NOK 262K
+1211% vs 2023
EBITDA margin
-1362.6%
-312% vs 2023
Equity ratio
58.9%
Financial strength
Net profit 2024
NOK -3,9M
-309% vs 2023
| Revenue | NOK 262K | +1211% |
| EBITDA | NOK -3,6M | -312% |
| Net profit | NOK -3,9M | -309% |
| Total assets | NOK 16,6M | +63% |
| Equity | NOK 9,8M | +96% |
| Employees | 5 | — |
Legal name
MEDTHINGS AS
Org number
924455314
Legal form
Aksjeselskap
NACE code
7112 · Engineering activities and related technical consultancy
Founded
21. januar 2020
Share capital
NOK 979 085
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Konsulentbistand, utvikling, produksjon, salg og markedsføring av produkter og tjenester innenfor velfredsteknologi og medisinsk teknologi, samt kjøp, salg og utleie av fast eiendom, kjøp og salg av verdipapirer, deltakelse i andre selskap, eiendomsutvikling samt øvrig handel og tjenester.
Address
Mosseveien 109, 1624 Gressvik
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 52 | 0 | 108 | 20 | 262 |
| Staff expenses | −0 | −765 | −731 | −356 | −54 | −177 |
| EBITDA | 0 | −897 | −845 | −512 | −868 | −3 574 |
| Depreciation & amort. | −0 | −0 | −0 | −2 | −5 | −5 |
| EBIT | 0 | −897 | −845 | −514 | −873 | −3 579 |
| Net financials | 0 | −0 | 0 | 0 | −76 | −296 |
| Profit before tax | 0 | −897 | −844 | −514 | −949 | −3 874 |
| Tax | −0 | −0 | −0 | −0 | −1 | −0 |
| Net profit | 0 | −897 | −844 | −514 | −948 | −3 874 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | 60 | 4 139 | 4 076 | 6 954 | 10 197 | 16 615 |
| Equity | 60 | 463 | 1 041 | 2 597 | 4 999 | 9 783 |
| Long-term debt | 0 | 2 400 | 2 400 | 2 400 | 2 400 | 5 999 |
| Short-term debt | 0 | 1 276 | 634 | 1 957 | 2 798 | 833 |
| Total debt | 0 | 3 676 | 3 034 | 4 357 | 5 198 | 6 832 |
EBITDA margin
-1362.6%
This company
15.8%
Market median
-8724% vs market
20192024
Equity ratio
58.9%
This company
38.2%
Market median
+54% vs market
20192024
Return on equity
-39.6%
This company
18.4%
Market median
-315% vs market
20192024
Net profit margin
-1477.4%
This company
8.1%
Market median
-18340% vs market
20192024
Asset turnover
0.02×
This company
1.12×
Market median
-98% vs market
20192024
Debt / equity
0.70×
This company
0.62×
Market median
+13% vs market
20192024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-11-27 – 2019-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
BL Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2026 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2026 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Bmt Holding As | Company | 34.6% | 34.6% | 2023 |
Nils7 As | Company | 29.0% | 29.0% | 2023 |
Procon Invest As | Company | 8.8% | 8.8% | 2023 |
Samak As | Company | 5.9% | 5.9% | 2023 |
T42 Holding As | Company | 4.9% | 4.9% | 2023 |
Neate As | Company | 2.5% | 2.5% | 2023 |
Charly Holding As | Company | 2.4% | 2.4% | 2023 |
Credio As | Company | 2.1% | 2.1% | 2023 |
Aleksandra Invest As | Company | 2.1% | 2.1% | 2023 |
See & Smile As | Company | 2.1% | 2.1% | 2023 |
Jok Holding As | Company | 1.7% | 1.7% | 2023 |
Haspro Holding As | Company | 1.7% | 1.7% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Nils7 As
MEDTHINGS AS Board members of MEDTHINGS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bjørn Lindgård Toreid | Chief Executive Officer | 0 companies |
| Anne Gerd Granås | Board of Directors | 0 companies |
| Per Andre Ødegård | Chairman | 0 companies |
| Marius Ferstad | Board of Directors | 0 companies |
| Lars Erik Andersen | Board of Directors | 0 companies |
| Nils Sverre Syvertsen | Board of Directors | 0 companies |
| Fredrik Hagen | Board of Directors | 0 companies |